Clinical Trials Directory

Trials / Unknown

UnknownNCT01689428

Ism1 Versus EmbryoGen Media for Embryo Culture in Previous Pregnancy Loss Cases

Prospective Randomized Controlled Trail to Assess the Efficacy of EmbryoGen Culture Medium to Improve Ongoing Pregnancy and Implantation Rates in IVF Treatments of Patients With a Previous History of Pregnancy Loss

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Biogenesi · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Recently, it has been suggested that culture of embryos in EmbryoGen medium can increase the live birth rate in IVF patients with a previous history of pregnancy loss. Couples requiring IVF treatment and with a past experience of miscarriage and/or biochemical pregnancy will be included in the study. Controlled ovarian stimulation protocol will consist of an agonist down regulation and follicular stimulation by recombinant FSH. Fertilization will be achieved by standard IVF or intracytoplasmic sperm injection. Fertilized eggs will be cultured in 6% CO2, 5% O2, 89% N2 atmosphere in microdrops. In the treatment group EmbryoGen culture medium (EG, Origio, Måløv, Denmark) will be adopted throughout the culture period. In the control group, inseminated oocytes will be cultured in standard culture conditions, i.e. IMS1 medium (ISM1, Origio, Måløv, Denmark), maintaining unchanged all other culture conditions. Procedures of embryo transfer, will be carried out on day 2 using EmbryoGen or ISM1 respectively. The endometrial support will be the same in the two groups. The investigators will consider ongoing clinical pregnancy as the primary outcome assuming a 25% of increment in ongoing clinical pregnancy rate in the group with EmbryoGen medium. As secondary outcome the investigators will assume a 5% of increment in ongoing implantation rate after 12 weeks in the group with EmbryoGen medium.

Conditions

Timeline

Start date
2012-09-01
Primary completion
2013-06-01
Completion
2013-09-01
First posted
2012-09-21
Last updated
2012-09-21

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01689428. Inclusion in this directory is not an endorsement.